Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. News
  7. Most relevant
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 01/17 06:12:06 am
192.5 CHF   -1.38%
01/12ZUR ROSE GROUP : Buy rating from Baader Bank
MD
01/10Zur Rose Group nominates Rongrong Hu as director
EQ
01/07ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about ZUR ROSE GROUP AG
01/12ZUR ROSE GROUP : Buy rating from Baader Bank
MD
01/10Zur Rose Group nominates Rongrong Hu as director
EQ
01/07ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
2021M.M Warburg Lowers Price Target on Zur Rose Group, Maintains Buy Recommendation
MT
2021ZUR ROSE GROUP : Receives a Buy rating from Warburg Research
MD
2021ZUR ROSE GROUP : Baader Bank remains its Buy rating
MD
2021Germany to miss deadline for full rollout of e-prescriptions
RE
2021ZUR ROSE GROUP : Jefferies reaffirms its Buy rating
MD
2021ZUR ROSE GROUP : Warburg Research remains its Buy rating
MD
2021ZUR ROSE GROUP : Baader Bank maintains a Buy rating
MD
2021ZUR ROSE GROUP : UBS remains a Sell rating
MD
2021GLOBAL MARKETS LIVE : Apple, Volkswagen, Uber, Rolls-Royce, Gamestop...
2021ZUR ROSE GROUP : Baader Bank maintains a Buy rating
MD
2021ZUR ROSE GROUP : Jefferies keeps its Buy rating
MD
2021ZUR ROSE GROUP : Warburg Research gives a Buy rating
MD
2021Zur Rose Raises $205 Million for Further Business Expansion
MT
2021CORRECTION : Zur Rose Plans Capital Increase for Tech Investments, Others
MT
2021Zur Rose Group successfully completed capital increase from authorised capital and set..
EQ
2021Zur Rose Targets Nearly $20 Million Via Share Issue
MT
2021Zur Rose Group decides on capital increase from authorised capital and starts accelerat..
EQ
2021ZUR ROSE GROUP : Baader Bank maintains a Buy rating
MD
2021ZUR ROSE GROUP : Sell rating from UBS
MD
2021ZUR ROSE : EHealth-Tec achieves first place in the TOP 100 competition
PU
2021ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
2021ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
2021Roche, Zur Rose Partner for Diabetes Management Project
MT
2021Roche and the Zur Rose Group announce collaboration to offer innovative health journeys..
PU
2021ZUR ROSE GROUP : Gets a Sell rating from UBS
MD
2021ZUR ROSE GROUP : Baader Bank maintains a Buy rating
MD
2021ZUR ROSE GROUP : UBS maintains a Sell rating
MD
2021ZUR ROSE GROUP : Receives a Buy rating from Warburg Research
MD
2021ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
2021ZUR ROSE : CEO To Take Over Chair's Role, Appoints New CEO
MT
2021ZUR ROSE : Revenue Grows 18% in First Nine Months of 2021; FY21 Revenue Growth Guidance Do..
MT
2021ZUR ROSE : continues to grow strongly Ad hoc announcement pursuant to Art. 53 LR
PU
2021ZUR ROSE GROUP : Board of Directors nominates Walter Oberhänsli as Chairman and appoints W..
PU
2021Zur Rose Group AG Announces Executive Changes
CI
2021Zur Rose Group AG Announces CEO Changes
CI
2021Zur Rose Group AG Provides Revenue Guidance for the Year 2021
CI
2021ZUR ROSE : Berenberg Downgrades Recommendation on Zur Rose Group to Hold From Buy, Maintai..
MT
2021ZUR ROSE GROUP : Berenberg gives a Neutral rating
MD
2021ZUR ROSE GROUP : UBS reiterates its Sell rating
MD
2021ZUR ROSE GROUP : Baader Bank reiterates its Buy rating
MD
2021ZUR ROSE GROUP : UBS reaffirms its Sell rating
MD
2021ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
2021ZUR ROSE GROUP : UBS reiterates its Sell rating
MD
2021ZUR ROSE : Health app Well heralds the future of healthcare
PU
2021ZUR ROSE GROUP : Receives a Sell rating from UBS
MD
2021ZUR ROSE GROUP : Gets a Buy rating from Warburg Research
MD
2021EUROPE : Defensive, travel stocks keep European shares afloat
RE
2021Zur Rose Group AG Re-Affirm Earnings Guidance for the Year 2021
CI
2021ZUR ROSE GROUP : Buy rating from Warburg Research
MD
2021ZUR ROSE GROUP : Morgan Stanley maintains a Buy rating
MD
2021Defensive, travel stocks keep European shares afloat
RE
2021ZUR ROSE GROUP : Baader Bank reiterates its Buy rating
MD
2021Zur Rose Group Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021ZUR ROSE : Presentation on the half-year results 2021
PU
2021ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
2021ZUR ROSE : accelerates growth in second quarter with revenue up 26 per cent Ad hoc announc..
PU
2021ZUR ROSE : Half-Year Report 2021
PU
2021ZUR ROSE : accelerates growth in second quarter with revenue up 26 per cent
EQ
2021ZUR ROSE GROUP : Deutsche Bank keeps its Buy rating
MD
2021ZUR ROSE : Release June 2021
PU
2021ANALYST RECOMMENDATIONS : Barclays, Chevron, Flutter, Netflix, Unilever...
2021ZUR ROSE GROUP : Jefferies keeps its Buy rating
MD
2021ZUR ROSE : Octavian Lowers Price Target on Zur Rose Group, Maintains Hold Recommendation
MT
2021Logitech to Replace Swatch in Two Swiss Indices in September
MT
2021ZUR ROSE GROUP : Baader Bank reaffirms its Buy rating
MD
2021ZUR ROSE GROUP : Baader Bank reaffirms its Buy rating
MD
2021ZUR ROSE GROUP : Gets a Sell rating from UBS
MD
2021GLOBAL MARKETS LIVE : Microsoft, HSBC, RyanAir, CureVac, Wise...
2021ZUR ROSE GROUP : UBS reiterates its Sell rating
MD
2021ZUR ROSE : Names New Chief Technology Officer
MT
2021ZUR ROSE GROUP STRENGTHENS GROUP MAN : Madhu Nutakki to become Chief Technology Officer
PU
2021Madhu Nutakki to Become Chief Technology Officer of Zur Rose Group AG on 1 August 2021
CI
1  2  3  4  5Next
Upcoming event on ZUR ROSE GROUP AG
03/24/22